A Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations

Clinical trial NCT05157776 · UNKNOWN

Trial details

NCT number: NCT05157776
Sponsor: Tongji University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC, Stage IIIA EGF-R Negative Non-Small Cell Lung Cancer ALK Negative NSCLC

Start date: 2021-10-28
Primary completion: 2024-10-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.